logo
Loading...

Shariah compliance overview

Not Halal

Eikon Therapeutics, Inc. Common Stock (EIKN) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs.

Eikon Therapeutics, Inc. Common Stock (EIKN) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity, Interest-bearing debt, Interest-bearing securities and assets.

Business Activity
100.00%Limit 5%Fail
Interest-bearing debt
52.51%Limit 30%Fail
Interest-bearing securities and assets
50.31%Limit 30%Fail
Dividend purification
100.00%Share of dividends to give to charityPurification calculator

Last updated: Nov 20, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Eikon Therapeutics, Inc. Common Stock (EIKN). Current Akinda screening label: Not Halal.